BACKGROUND: In rapidly lung deteriorating patients, urgent lung transplantation (ULT) seems the only definitive therapy. Few publications on this topic report conflicting results, putting a word of caution about ULT programs. METHODS: A national ULT program was introduced in 2010: patients on mechanical support may be transplanted with the first available graft. We reviewed the experience of three national center, focusing on post-operative outcomes after ULT. RESULTS: Ten patients (17.5%) died awaiting transplantation, while 47 underwent LT with a median urgent waiting list time of 6 days. Pre-operatively, 4.3% of patients were supported only by mechanical ventilation (MV), 55.3% by extracorporeal membrane oxygenation (ECMO) and the remaining 40.4% by both. The main indication was cystic fibrosis (64%). Median recipient lung allocation score was 72. In-hospital mortality was 19%. MV and ECMO median duration of 7 and 3 days, respectively while intensive care unit (ICU) and hospital stay were 20 and 46 days, respectively. At long-term, 1- and 3-year survival rate were 74% and 70%, respectively. Highly impact risk factors for in-hospital mortality were both presence and duration of preoperative veno-arterial ECMO and pre-transplant C-reactive protein level. CONCLUSIONS: ULT program allows transplantation in a significant percentage of patients with acceptable results. Pre-operative recipient selection is mandatory to improve clinical outcomes. 2019 Journal of Thoracic Disease. All rights reserved.
BACKGROUND: In rapidly lung deteriorating patients, urgent lung transplantation (ULT) seems the only definitive therapy. Few publications on this topic report conflicting results, putting a word of caution about ULT programs. METHODS: A national ULT program was introduced in 2010: patients on mechanical support may be transplanted with the first available graft. We reviewed the experience of three national center, focusing on post-operative outcomes after ULT. RESULTS: Ten patients (17.5%) died awaiting transplantation, while 47 underwent LT with a median urgent waiting list time of 6 days. Pre-operatively, 4.3% of patients were supported only by mechanical ventilation (MV), 55.3% by extracorporeal membrane oxygenation (ECMO) and the remaining 40.4% by both. The main indication was cystic fibrosis (64%). Median recipient lung allocation score was 72. In-hospital mortality was 19%. MV and ECMO median duration of 7 and 3 days, respectively while intensive care unit (ICU) and hospital stay were 20 and 46 days, respectively. At long-term, 1- and 3-year survival rate were 74% and 70%, respectively. Highly impact risk factors for in-hospital mortality were both presence and duration of preoperative veno-arterial ECMO and pre-transplant C-reactive protein level. CONCLUSIONS: ULT program allows transplantation in a significant percentage of patients with acceptable results. Pre-operative recipient selection is mandatory to improve clinical outcomes. 2019 Journal of Thoracic Disease. All rights reserved.
Authors: Antoine Roux; Laurence Beaumont-Azuar; Abdul Monem Hamid; Sandra De Miranda; Dominique Grenet; Guillaume Briend; Pierre Bonnette; Philippe Puyo; François Parquin; Jerome Devaquet; Gregoire Trebbia; Elise Cuquemelle; Benoit Douvry; Clément Picard; Morgan Le Guen; Alain Chapelier; Marc Stern; Edouard Sage Journal: Transpl Int Date: 2015-05-27 Impact factor: 3.782
Authors: Lars H Lund; Kiran K Khush; Wida S Cherikh; Samuel Goldfarb; Anna Y Kucheryavaya; Bronwyn J Levvey; Bruno Meiser; Joseph W Rossano; Daniel C Chambers; Roger D Yusen; Josef Stehlik Journal: J Heart Lung Transplant Date: 2017-07-20 Impact factor: 10.247
Authors: Geert M Verleden; Lieven Dupont; Jonas Yserbyt; Veronique Schaevers; Dirk Van Raemdonck; Arne Neyrinck; Robin Vos Journal: J Thorac Dis Date: 2017-09 Impact factor: 2.895
Authors: Jason D Christie; Scarlett Bellamy; Lorraine B Ware; David Lederer; Denis Hadjiliadis; James Lee; Nancy Robinson; A Russell Localio; Keith Wille; Vibha Lama; Scott Palmer; Jonathan Orens; Ann Weinacker; Maria Crespo; Ejigaehu Demissie; Stephen E Kimmel; Steven M Kawut Journal: J Heart Lung Transplant Date: 2010-07-22 Impact factor: 10.247
Authors: David P Mason; Lucy Thuita; Edward R Nowicki; Sudish C Murthy; Gösta B Pettersson; Eugene H Blackstone Journal: J Thorac Cardiovasc Surg Date: 2010-03 Impact factor: 5.209
Authors: Sakhee Kotecha; Jamie Hobson; Jeremy Fuller; Eldho Paul; Bronwyn J Levvey; Helen Whitford; Miranda Paraskeva; David McGiffin; Gregory I Snell; Glen P Westall Journal: Ann Thorac Surg Date: 2017-09-28 Impact factor: 4.330